BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36900323)

  • 1. The Tumor Coagulome as a Transcriptional Target and a Potential Effector of Glucocorticoids in Human Cancers.
    Racine F; Louandre C; Godin C; Chatelain B; Prekovic S; Zwart W; Galmiche A; Saidak Z
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Landscape of the Coagulome of Oral Squamous Cell Carcinoma.
    Lottin M; Soudet S; Fercot J; Racine F; Demagny J; Bettoni J; Chatelain D; Sevestre MA; Mammeri Y; Lamuraglia M; Galmiche A; Saidak Z
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coagulome of oral squamous cell carcinoma: examining the role and regulation of coagulation in oral cancers using a systems approach.
    Racine F; Soudet S; Sevestre MA; Galmiche A; Saidak Z
    Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):73-77. PubMed ID: 36912218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment.
    Saidak Z; Soudet S; Lottin M; Salle V; Sevestre MA; Clatot F; Galmiche A
    Cancer Immunol Immunother; 2021 Apr; 70(4):923-933. PubMed ID: 33057845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of coagulome in the tumor immune microenvironment.
    Wahab R; Hasan MM; Azam Z; Grippo PJ; Al-Hilal TA
    Adv Drug Deliv Rev; 2023 Sep; 200():115027. PubMed ID: 37517779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines.
    Halleux CM; Declerck PJ; Tran SL; Detry R; Brichard SM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4097-105. PubMed ID: 10566656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
    Zhu C; Jiang L; Xu J; Ren A; Ju F; Shu Y
    Pathol Res Pract; 2020 Apr; 216(4):152885. PubMed ID: 32113794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway.
    Pew T; Zou M; Brickley DR; Conzen SD
    Endocrinology; 2008 May; 149(5):2637-45. PubMed ID: 18239069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of P2Y
    Bondu V; Bitting C; Poland VL; Hanson JA; Harkins MS; Lathrop S; Nolte KB; Lawrence DA; Buranda T
    Front Cell Infect Microbiol; 2018; 8():169. PubMed ID: 29930915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells.
    Sasaki CY; Lin H; Passaniti A
    J Cell Physiol; 1999 Oct; 181(1):1-13. PubMed ID: 10457348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of plasminogen activator inhibitor (PAI)-1 expression in a human trophoblast cell line by glucocorticoid (GC) and transforming growth factor (TGF)-beta.
    Ma Y; Ryu JS; Dulay A; Segal M; Guller S
    Placenta; 2002 Nov; 23(10):727-34. PubMed ID: 12398812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
    Fukumoto S; Allan EH; Zeheb R; Gelehrter TD; Martin TJ
    Endocrinology; 1992 Feb; 130(2):797-804. PubMed ID: 1733726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
    Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
    Lundgren CH; Sawa H; Sobel BE; Fujii S
    Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism and significance of synergistic induction of the expression of plasminogen activator inhibitor-1 by glucocorticoid and transforming growth factor beta in human ovarian cancer cells.
    Pan XY; Wang Y; Su J; Huang GX; Cao DM; Qu S; Lu J
    Mol Cell Endocrinol; 2015 May; 407():37-45. PubMed ID: 25770462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulome and the tumor microenvironment: an actionable interplay.
    Galmiche A; Rak J; Roumenina LT; Saidak Z
    Trends Cancer; 2022 May; 8(5):369-383. PubMed ID: 35027336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells.
    Kimura H; Li X; Torii K; Okada T; Kamiyama K; Mikami D; Kasuno K; Takahashi N; Yoshida H
    Clin Exp Nephrol; 2011 Feb; 15(1):34-40. PubMed ID: 21042829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
    Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
    Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa.
    Pasini FS; Brentani MM; Kowalski LP; Federico MH
    Head Neck; 2001 Sep; 23(9):725-32. PubMed ID: 11505481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.